Promising molecular mechanisms responsible for gemcitabine resistance in cancer
2015 · Genes & Diseases · 179 citations
https://doi.org/10.1016/j.gendis.2015.07.003
Y
Yanfei Jia
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
141
Papers
2.2K
Citations
26
h-index
61
i10-index
Yanfei Jia is an academic researcher from Weifang Medical University. The author has contributed to research in topics: RNA modifications and cancer & Nicotinic Acetylcholine Receptors Study & Epigenetics and DNA Methylation. The author has an h-index of 26, co-authored 120 publications.
ORCID: 0000-0002-0670-1604Papers by this author
worksExpression of immunoglobulin-like transcript (ILT)2 and ILT3 in human gastric cancer and its clinical significance
2012 · Molecular Medicine Reports · 98 citations
https://doi.org/10.3892/mmr.2012.744
The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer
2018 · Oncogene · 94 citations
https://doi.org/10.1038/s41388-018-0553-0
Differentiated embryonic chondrocyte-expressed gene 1 is associated with hypoxia-inducible factor 1α and Ki67 in human gastric cancer
2013 · Diagnostic Pathology · 44 citations
https://doi.org/10.1186/1746-1596-8-37
Single-cell analysis of gastric signet ring cell carcinoma reveals cytological and immune microenvironment features
2023 · Nature Communications · 42 citations
https://doi.org/10.1038/s41467-023-38426-4
lncRNA DLEU2 promotes gastric cancer progression through ETS2 via targeting miR-30a-5p
2021 · Cancer Cell International · 40 citations
https://doi.org/10.1186/s12935-021-02074-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat